Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Custom recombinant protein production plays a major role in advanced healthcare and is the most efficient technique used in life sciences. Recombinant proteins are used in a wide range of applications in research, biotechnology, and medicine. Increasing funding in the field of life sciences is expected to propel growth of the custom recombinant protein production services market. Recombinant protein is a manipulated form of protein, which is encoded by genes. It is used in production of large quantities of protein, which is further used for manufacturing of therapeutic commercial products. Increasing government initiatives and funding in the field of life sciences is expected to boost growth of the market. For instance, Life Sciences Greenhouse of Central Pennsylvania offers early stage funding of up to US$ 1-2 million in the form of convertible debt or equity financing to viable life sciences companies, which have significant potential for commercial growth.

Global Custom Recombinant Protein Production Services Market - Impact of Coronavirus (COVID-19) Pandemic

The spread of the novel coronavirus has hampered growth of the pharmaceutical industry. In December 2019, in China’s Wuhan City, a cluster of pneumonia cases were reported by Chinese health authorities. The pneumonia causative agent was identified as a novel coronavirus named COVID-19. This virus spread rapidly across the globe, thus causing a concerning number of fatalities. In March 2020, the World Health Organization (WHO) declared the COVID-19 as a global pandemic and suggested implementation of strict measures to minimize the spread of this disease. The pandemic has slowed down growth of the healthcare sector and led to a disturbance in the supply chain.

Moreover, governments across various countries have implemented nationwide lockdowns to curb the spread of COVID-19. Similarly, in various countries across the world, healthcare companies are facing problems of continuing its supply chain operations. The slowdown of the healthcare companies’ supply chain has also impacted negatively on growth of the global custom recombinant protein production services market.

The global custom recombinant protein production services market size is estimated to be valued at US$ 3575.3 million in 2020 and is expected to exhibit a CAGR of 11.2% over the forecast period (2020 – 2027).

Figure 1. Global Custom Recombinant Protein Production Services Market Share (%) Analysis, By Expression System, 2020

Custom Recombinant Protein Production Services  | Coherent Market Insights

Global Custom Recombinant Protein Production Services Market - Restraints

However, high cost of recombinant protein for particular requirement is expected to hinder the market growth. The price of protein synthesis services range from US$ 3 to US$ 160 per amino acid depending upon the purity of the desired product. Moreover, the price of recombinant protein production services varies from US$ 500 to US$ 5,000 per milligram depending upon the protein production expression systems, species of the proteins, and the family to which these recombinant proteins belong.

request-sample

Custom Recombinant Protein Production Services Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 2,338.3 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 11.2% 2027 Value Projection: US$ 7,517.2 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Expression System: Mammalian, Bacteria, Insect, Yeast, Others.
  • By End User: Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, Others.
Companies covered:

GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, Sino Biological Inc., and SignalChem Lifesciences Corporation

Growth Drivers:
  • Increasing research and development and product launches
Restraints & Challenges:
  • High cost of recombinant protein for particular requirement

Global Custom Recombinant Protein Production Services Market – Regional Analysis

On the basis of region, the global custom recombinant protein production services market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing research and development and product launches in North America is expected to bolster the market growth. For instance, in 2020, researcher from University of California - San Diego found that genome-editing techniques could eliminate up to 70 percent of the contaminating protein by mass in recombinant-protein drugs produced by the workhorses of mammalian cells –such as Chinese Hamster Ovary (CHO) cells. With such advanced research findings, this helps to boost the production services of custom recombinant protein.

Moreover, the companies in the region are focused on adopting strategic acquisitions to expand their geographic presence. For instance, in 2017, Eurofins Scientific acquired DiscoverX to improve research productivity and accelerate the discovery and development of new drugs. The acquisition is also expected to create a robust portfolio of kinase products and services in the market.

Furthermore, in December 2019, iBio, Inc. unveiled the FastGlycaneering Development Service, which has an array of new glycosylation technologies for engineering high-performance recombinant proteins. By using iBio’s plant-based manufacturing services, the biopharmaceutical companies and biosimilar producers are able to take the advantage of low-cost afucosylation controls, oligomannose modification capabilities, and more custom glycosylation used for rapidly develop best quality novel antibody and biosimilars drugs.

Figure 2. Global Custom Recombinant Protein Production Services Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Custom Recombinant Protein Production Services  | Coherent Market Insights

Global Custom Recombinant Protein Production Services Market - Competitive Landscape

Key players operating in the global custom recombinant protein production services market include GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, Sino Biological Inc., and SignalChem Lifesciences Corporation.

Recombinant proteins are used for the development of novel therapies for severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique known as recombinant DNA (rDNA) technology. Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research.

Market Dynamics

Increasing demand for recombinant proteins for basic research drives growth of the custom recombinant protein production services market. Recombinant therapeutic proteins are one of the fast-growing areas in molecular medicine. Various biopharmaceutical companies are focusing on development of biologics and subsequently biosimilars. Moreover, increasing expenditure in research has supported the market growth. According to Science & Engineering Indicators 2020 report published by National Science Board of the U.S, the R&D spending in the U.S. was around US$ 548 billion in 2017.

Moreover, major players in the market are focused on launching new facilities to cater to increasing demand for research and development, which is expected to drive the market growth. For instance, in 2016, ATUM established a new state-of-the-art bio-production facility in Newark, California, for rapid expansion and to provide better services to the customers.

However, high cost of protein expression systems and complex manufacturing procedures are the major factors restraining the market growth over the forecast period. For instance, the price of recombinant protein production services varies from US$ 500 to US$ 5,000 per milligram depending upon the protein production expression systems, species of the proteins, and the family to which these recombinant proteins belong.

Key features of the study:

  • This report provides in-depth analysis of the custom recombinant protein production services market, and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020 – 2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global custom recombinant protein production services market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, Sino Biological Inc, and SignalChem Lifesciences Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the custom recombinant protein production services market

Detailed Segmentation:

  • Global Custom Recombinant Protein Production Services Market, By Expression System:
    • Mammalian
    • Bacteria
    • Insect
    • Yeast
    • Others
  • Global Custom Recombinant Protein Production Services, By End User:
    • Research Institutes
    • Biotechnology and Pharmaceutical Companies
    • Contract Research Organizations
    • Others
  • Global Custom Recombinant Protein Production Services Market, By Region:
    • North America
      • By Expression System:
        • Mammalian
        • Bacteria
        • Insect
        • Yeast
        • Others
      • By End User:
        • Research Institutes
        • Biotechnology and Pharmaceutical Companies
        • Contract Research Organizations
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Expression System:
        • Mammalian
        • Bacteria
        • Insect
        • Yeast
        • Others
      • By End User:
        • Research Institutes
        • Biotechnology and Pharmaceutical Companies
        • Contract Research Organizations
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Expression System:
        • Mammalian
        • Bacteria
        • Insect
        • Yeast
        • Others
      • By End User:
        • Research Institutes
        • Biotechnology and Pharmaceutical Companies
        • Contract Research Organizations
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Expression System:
        • Mammalian
        • Bacteria
        • Insect
        • Yeast
        • Others
      • By End User:
        • Research Institutes
        • Biotechnology and Pharmaceutical Companies
        • Contract Research Organizations
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Expression System:
        • Mammalian
        • Bacteria
        • Insect
        • Yeast
        • Others
      • By End User:
        • Research Institutes
        • Biotechnology and Pharmaceutical Companies
        • Contract Research Organizations
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Expression System:
        • Mammalian
        • Bacteria
        • Insect
        • Yeast
        • Others
      • By End User:
        • Research Institutes
        • Biotechnology and Pharmaceutical Companies
        • Contract Research Organizations
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • GenScript Biotech Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Applied Biological Materials Inc.
    • Eurofins Pharma Discovery Services
    • Abgent
    • OriGene Technologies, Inc.
    • Crown Bioscience, Inc.
    • BPS Bioscience, Inc.
    • ProteoGenix
    • Kempbio, Inc.
    • Novoprotein
    • Premas Biotech
    • Trenzyme GmbH
    • Atum
    • Novus Biologicals, LLC
    • Icosagen AS
    • LakePharma, Inc.
    • Proteos, Inc.
    • Aldevron
    • Sino Biological Inc.
    • SignalChem Lifesciences Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Expression System
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Pipeline Analysis
    • Reimbursement Scenario
    • Pest Analysis
    • Regulatory Scenario
    • Collaborations and Agreements
    • Market Trends
  4. Global Custom Recombinant Protein Production Services Market, By Expression System, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Mammalian
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Bacteria
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Insect
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Yeast
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Custom Recombinant Protein Production Services Market, By End User, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Biotechnology and Pharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Contract Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Custom Recombinant Protein Production Services Market, By Region, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Expression System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Expression System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Expression System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Expression System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Expression System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Expression System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • GenScript Biotech Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Applied Biological Materials Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eurofins Pharma Discovery Services
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abgent
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • OriGene Technologies, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Crown Bioscience, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BPS Bioscience, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ProteoGenix
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kempbio, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novoprotein
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Premas Biotech
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Trenzyme GmbH
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Atum
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novus Biologicals, LLC
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Icosagen AS
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • LakePharma, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Proteos, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Aldevron
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sino Biological Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SignalChem Lifesciences Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 37 market data tables and 29 figures on "Custom Recombinant Protein Production Services Market - Global forecast to 2027”.

Frequently Asked Questions

The global custom recombinant protein production services market is expected to register a CAGR of 11.2% during the forecast period (2020-2027).
The value of the global custom recombinant protein production services market is estimated to be US$ 2,338.3 million in 2020.
The prominent players in the global custom recombinant protein production services market include GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, Sino Biological Inc., and SignalChem Lifesciences Corporation.
The global custom recombinant protein production services market is expected to be valued at US$ 7,517.2 million in 2027.
North America is a major region in the global custom recombinant protein production services market.
Increasing research and development, and product launches are expected to drive growth of the global custom recombinant protein production services market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner